Business Description
Renerve Ltd
ISIN : AU0000358616
Description
Renerve Ltd specializes in developing a range of ready-to-use products that are cleaner, safer for repairing or replacing damaged peripheral nerves, resulting in good patient outcomes. Its product candidates include NervAlign Bionic Nerve, NervAlign Nerve Graft, and NervAlign Nerve Cuff [The NervAlign Nerve Guide Matrix, The NervAlign Nerve Conduit, The NervAlign Bionic Replacement Nerve]. The company operates in New Zealand and USA. Maximum of revenue is from USA.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 25.52 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.7 | |||||
Beneish M-Score | 3.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | -32.6 | |||||
3-Year EPS without NRI Growth Rate | -35.7 | |||||
3-Year FCF Growth Rate | -21.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.09 | |||||
9-Day RSI | 49.26 | |||||
14-Day RSI | 47.26 | |||||
3-1 Month Momentum % | -22 | |||||
6-1 Month Momentum % | -32.17 | |||||
12-1 Month Momentum % | -35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.77 | |||||
Quick Ratio | 6.42 | |||||
Cash Ratio | 4.83 | |||||
Days Inventory | 567.22 | |||||
Days Sales Outstanding | 636.1 | |||||
Days Payable | 755.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -24.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.46 | |||||
Operating Margin % | -1641.44 | |||||
Net Margin % | -1383.48 | |||||
EBITDA Margin % | -1473.27 | |||||
FCF Margin % | -1371.17 | |||||
OCF Margin % | -1319.22 | |||||
ROE % | -79.03 | |||||
ROA % | -69.52 | |||||
ROIC % | -465.98 | |||||
ROC (Joel Greenblatt) % | -863.97 | |||||
ROCE % | -83.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 40 | |||||
PB Ratio | 2.5 | |||||
Price-to-Tangible-Book | 2.67 | |||||
EV-to-EBIT | -1.96 | |||||
EV-to-EBITDA | -1.96 | |||||
EV-to-Revenue | 28.8 | |||||
EV-to-FCF | -2.14 | |||||
| Price-to-Net-Current-Asset-Value | 2.67 | |||||
| Price-to-Net-Cash | 4 | |||||
Earnings Yield (Greenblatt) % | -51.16 | |||||
FCF Yield % | -33.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Renerve Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.333 | ||
| EPS (TTM) (A$) | -0.032 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 52.16 | ||
| 14-Day RSI | 47.26 | ||
| 14-Day ATR (A$) | 0.003216 | ||
| 20-Day SMA (A$) | 0.0815 | ||
| 12-1 Month Momentum % | -35 | ||
| 52-Week Range (A$) | 0.069 - 0.22 | ||
| Shares Outstanding (Mil) | 172.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Renerve Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Renerve Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Renerve Ltd Frequently Asked Questions
What is Renerve Ltd(ASX:RNV)'s stock price today?
The current price of ASX:RNV is A$0.08. The 52 week high of ASX:RNV is A$0.22 and 52 week low is A$0.07.
When is next earnings date of Renerve Ltd(ASX:RNV)?
The next earnings date of Renerve Ltd(ASX:RNV) is .
Does Renerve Ltd(ASX:RNV) pay dividends? If so, how much?
Renerve Ltd(ASX:RNV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Renerve Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers